Question 1

What are the potential side effects of armodafinil compared to PROVIGIL?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL clinical trial (NCT00236080). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL clinical trial (NCT00236080). Contact the study team or your healthcare provider for specific answers.

Question 3

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL clinical trial (NCT00236080). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any dietary restrictions I need to follow during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL clinical trial (NCT00236080). Contact the study team or your healthcare provider for specific answers.

Question 5

How long will I need to stay at the clinic for monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL clinical trial (NCT00236080). Contact the study team or your healthcare provider for specific answers.

Question 6

Will I be able to continue my current medications while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL clinical trial (NCT00236080). Contact the study team or your healthcare provider for specific answers.

What this study is about